A rare ovarian tumor - Sertoli-Leydig cell tumor with heterologous element

MedGenMed Medscape General Medicine

Volumn 9, Issue 4, 2007, Pages

  Tandon, Rimpy ^a   Goel, Poonam ^a   Saha, Pradip Kuman ^a   Takkar, Navneet ^a   Punia, R P S ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; ECHOGRAPHY; FEMALE; GYNECOLOGICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LEYDIG CELL TUMOR; NEEDLE BIOPSY; OVARY TUMOR; PERITONEAL BIOPSY; SALPINGOOOPHORECTOMY; SERTOLI CELL TUMOR; SEX CORD TUMOR; TUMOR VOLUME; ANDROBLASTOMA; CANCER INVASION; CANCER STAGING; FOLLOW UP; IMMUNOHISTOCHEMISTRY; METHODOLOGY; OVARIECTOMY; PATHOLOGY; RARE DISEASE; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; BIOPSY, NEEDLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; RARE DISEASES; RISK ASSESSMENT; SERTOLI-LEYDIG CELL TUMOR; TREATMENT OUTCOME;

EID: 36749097866     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumours. A clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985;9:543-569. Abstract
2. Dietrich JE, Kaplan A, Lopez H, Jaffee I. A case of poorly differentiated Sertoli-Leydig tumour of the ovary. J Pediatr Adolesc Gynecol. 2004;17:49-52. Abstract
3. Lantzsch T, Stoerer S, Lawrenz K, Buchmann J, Strauss H-G, Koelbl H. Sertoli-Leydig cell tumour. Arch Gynecol Obstet. 2001;264:206-208. Abstract
4. Mathur SR, Bhatia N, Rao IS, Singh MK.Sertoli Leydig cell tumour with heterologous gastrointestinal epithelium: a case report. Indian J Pathol Microbiol. 2003;46:91-93. Abstract
5. Meyer R. Tubulare(testikulare) und solide Formen des Andreioblastoma ovarii and ihre Beziehung zur Vermannlichung, Beitr Z path Anat Allg Path. 1930;84:485-520.
6. McLester JB. Arrhenoblastoma: a special type of teratoma .Arch Interm Med. 1936; 57:773-786.
7. Zaloudek C, Norris H. Sertoli-Leydig cell tumors of the ovary. A clinicopathological study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol. 1984;8:405-418. Abstract
8. Kriplani A, Agarwal N, Roy KK, Manchanda R, Singh MK. Laproscopic management of Sertoli-Leydig cell tumours of the ovary. A report of two cases. J Reprod Med.2001;46:493-496. Abstract
9. Sood AK, Gershenson DM. Management of early-stage ovarian cancer. In: Bristow RE, Karlan BY, eds. Surgery for Ovarian Cancer: Principles and Practice. London, UK: Taylor and Francis; 2005:57-86.
10. Gershenson DM, Copeland LJ, Kavanagh JJ, et al. Treatment of metastatic tumour of the ovary with cisplastin, doxorubicin and cyclophosphamide. Obstet Gynecol. 1987;70:765-769. Abstract
11. Schwartz PE, Smith JP. Treatment of ovarian stromal tumours. Am J Obstet Gynecol. 1976;125:402-411. Abstract
12. Gershenson DM, Morris M, Burke TW, et al. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996;87;527-531. Abstract